By characterization the effects of NHERF1 with its regulation on tumor cell responses to crizotinib, we have demonstrated a dynamic interplay between NHERF1 and ALK signaling in lung adenocarcinoma cells. The gene discussed is NHERF1; the disease is lung adenocarcinoma.